DocWire News Editors

DocwireNews

The rate of students at risk for anaphylaxis is rising, and up to 6% of students self-report a food allergy, according to a presentation at the ACAAI annual meeting. Although the rate of epinephrine use in schools is also rising, it is administered in only 64% of cases of anaphylaxis that occur in schools, according to the EPIPEN4SCHOOLS&reg; program, and only 59% of schools cite epinephrine as their standard first-line therapy for anaphylaxis.Furthermore, research shows that adolescents in particular are not consistently self-carrying their epinephrine auto-injectors. Therefore, Julie Wang, MD, of the Icahn School of Medicine at Mount Sinai in New York City, urged participants to implement best practices for anaphylaxis management in schools.&rdquo;Wang stressed that management of anaphylaxis in schools depends on &ldquo;successful implementation of proactive plans for allergen avoidance, preparedness for reactions, and ready access to epinephrine.&rdquo; Allergists play a key role in achieving those objectives, she said.The speaker provided detailed examples of ways to prepare schools. Families have indicated that they would like schools to stock epinephrine, provide lunch menus that contain allergen information, put ingredient labels on food items, and implement food allergy education for students. Other practices encouraged by school nurses include anaphylaxis training for staff, designated lunch areas, and food guidelines for classrooms. Financial, temporal, and attitudinal barriers sometimes prevent implementation.Wang encouraged allergists and other doctors in the audience to play a larger role in communicating the diagnoses to schools and pointing out the risks. Specifically, they should provide written allergy and anaphylaxis emergency plans (templates are available from the American Academy of Pediatrics), she noted. Allergists also should provide prescriptions for epinephrine auto-injectors and help schools create plans for effective allergen avoidance. Physicians also can encourage parents and caregivers to provide their children&rsquo;s schools with medical information and medications&mdash;and to update it as necessary.Importantly, she said, doctors should educate and remind all involved that anaphylaxis is potentially life-threatening. Therefore, when in doubt, people should administer epinephrine. In fact, some have advocated that patients with any history of severe reactions to stings or food allergens should receive epinephrine before symptoms even begin.Training the school staff increases their knowledge, attitudes, and confidence. Such education should be based on evidence-based recommendations and should include all staff, not just school nurses. Wang referred the audience to resources including programs from their own states and school districts, the Centers for Disease Control and Prevention, the National Association of School Nurses, AllergyHome, and Food Allergy Research &amp; Education&reg;.Finally, she reminded attendees to have frequent discussions with patients and families, encouraging students to take responsibility for self-care that is developmentally appropriate.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Helping Families and Schools Manage Anaphylaxis

ACAAI 2018

The rate of students at risk for anaphylaxis is rising, and up to 6% of students self-report a food allergy, according to a presentation at the ACAAI annual meeting. Although ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe